Overview

Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis

Status:
Recruiting
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Bawei Shenqi Pill is effective in the treatment of active ankylosing spondylitis (AS).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Treatments:
Meloxicam